Linden Advisors LP Invests $6.09 Million in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU)

Linden Advisors LP acquired a new position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 600,000 shares of the company’s stock, valued at approximately $6,090,000.

Several other large investors have also recently added to or reduced their stakes in OACCU. Rangeley Capital LLC acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 4th quarter worth approximately $101,000. Athos Capital Ltd acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at $507,000. Kepos Capital LP bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 4th quarter worth $709,000. Affinity Asset Advisors LLC acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter valued at $2,538,000. Finally, Whitebox Advisors LLC bought a new position in Oaktree Acquisition Corp. III Life Sciences during the fourth quarter valued at about $2,532,000.

Oaktree Acquisition Corp. III Life Sciences Stock Performance

Shares of Oaktree Acquisition Corp. III Life Sciences stock opened at $10.54 on Monday. Oaktree Acquisition Corp. III Life Sciences has a 52 week low of $9.99 and a 52 week high of $10.60. The business has a 50-day simple moving average of $10.35.

Oaktree Acquisition Corp. III Life Sciences Company Profile

We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.